ArticleBreast cancer research : BCR2014

PIK3CA mutations in androgen receptor-positive triple negative breast cancer confer sensitivity to the combination of PI3K and androgen receptor inhibitors.

Brian D Lehmann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.